Agomab Therapeutics vs Tesla

Side-by-side comparison of AI visibility scores, market position, and capabilities

Agomab Therapeutics

EmergingBioTech

Fibrosis Therapeutics (Crohn's & IPF)

Nasdaq IPO Feb 2026 (~$200M raised, ~$780M valuation, ticker AGMB). Positive Phase 2a data for ontunisertib in fibrostenosing Crohn's. Phase 1 data for AGMB-447 in IPF. Gut-restricted ALK5 inhibitor.

About

Agomab Therapeutics went public on Nasdaq in February 2026, raising approximately $200 million at an ~$780 million valuation (ticker: AGMB), becoming one of the first European biotechs to list in the US in 2026. Agomab is developing ontunisertib — the only clinical-stage gut-restricted ALK5/TGFβR1 inhibitor for fibrostenosing Crohn's disease, a severe complication where intestinal fibrosis causes strictures requiring repeated surgery. The company also has AGMB-447 in Phase 1 for idiopathic pulmonary fibrosis (IPF), using lung-restricted delivery of the same mechanism.

Full profile

Tesla

LeaderAutomotive

Electric Vehicles

Tesla (TSLA) reported $97.7B revenue in FY2024, up 1% YoY. 1.8M vehicles delivered. Market cap ~$900B. 140,000+ employees. Austin, TX. FSD (Full Self-Driving), Optimus humanoid robot, Dojo AI training supercomputer.

AI VisibilityBeta
Overall Score
A88
Category Rank
#1 of 2
AI Consensus
90%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
82
Gemini
82

About

Tesla is an electric vehicle and clean energy company founded in 2003 by Martin Eberhard and Marc Tarpenning in San Carlos, California, and subsequently co-founded and led by Elon Musk, who joined as chairman and lead investor in 2004. The company was built on the premise that electric vehicles could be desirable, high-performance automobiles — not compromise products — and that compelling EVs would accelerate the world's transition to sustainable energy. Musk's strategy, articulated in the 2006 "Secret Master Plan," was to start with a premium sports car (Roadster), use the proceeds to build a more affordable sedan (Model S), and ultimately produce a mass-market vehicle (Model 3). Tesla trades on Nasdaq under the ticker TSLA and has since expanded its mission to encompass solar energy, stationary storage, and autonomous driving.\n\nTesla's product portfolio spans the Model 3 (sedan), Model Y (compact SUV — the world's best-selling vehicle in 2023), Model S (premium sedan), Model X (premium SUV), Cybertruck (full-size electric pickup), and the Tesla Semi commercial truck. The company's energy business includes the Powerwall home battery, Megapack utility-scale storage, and Solar Roof installations. Tesla's Full Self-Driving (FSD) software suite provides driver assistance capabilities up to supervised autonomous driving, with a paid subscription and per-vehicle purchase option. Tesla operates a proprietary Supercharger network of 50,000+ charging stations globally, a significant infrastructure moat that has become accessible to competing EV brands through industry NACS adapter adoption.\n\nTesla reported FY2024 revenue of $97.7 billion, up approximately 1% year over year, with 1.8 million vehicles delivered and a market capitalization of approximately $900 billion — making it one of the ten most valuable companies in the world. The company employs 140,000+ people and operates Gigafactories in Austin (Texas), Fremont (California), Shanghai, Berlin, and Nevada. Despite increasing competition from BYD in China and European automakers globally, Tesla's vertical integration, software-defined vehicle architecture, FSD capability, and energy storage business position it as the defining company of the electric transportation and distributed energy era.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.